Phenomenex Inc. announced it has signed a definitive agreement to be acquired by Danaher Corporation. Phenomenex will operate as a standalone operating company, retaining the Phenomenex brand, its personnel and site locations.
"Phenomenex is a widely recognizable brand that we are proud to say is highly respected and well established as providing high-quality consumables to the scientific community worldwide," said Fasha Mahjoor, CEO, Phenomenex. "Joining Danaher will allow us to maintain the high pace of innovation that our customers and international distributors have come to expect from us. This is our opportunity to further expand our R&D activities, benefit our customers with a more diversified product portfolio and reinforce our market leadership."
"We are thrilled to have Phenomenex join Danaher's life sciences portfolio of businesses, which include SCIEX, Beckman Coulter Life Sciences, Pall, Leica Microsystems and Molecular Devices," said Dan Daniel, Executive Vice President, Danaher. "Phenomenex is a strong business characterized by high growth rates and margins and excellent growth prospects driven by increasing analytical testing needs in the health, research and environmental segments. The Danaher Business System (DBS) has a strong track record of helping businesses rapidly scale operations and create long-term customer value. We look forward to supporting the Phenomenex team in leveraging DBS tools for growth and welcoming them to our Life Sciences team."
The transaction, which is expected to close by late 2016, is subject to customary closing conditions and regulatory approvals.
Phenomenex Opens New Office in India
Phenomenex Inc. announced that it has expanded its international subsidiary network to serve India directly from a new office in Hyderabad. The new entity, which opened this month, will serve research communities throughout India with sales and service teams that sell all Phenomenex produc ... more
Phenomenex announced that president and CEO Fasha Mahjoor has been selected as a finalist for Ernst & Young's Greater Los Angeles Entrepreneur of the Year 2010 award. According to Ernst & Young LLP, the awards program recognizes entrepreneurs who demonstrate extraordinary success in the ar ... more
Phenomenex Launches Chiral Screening Service
Phenomenex Inc. announces a Chiral Screening Service for customers in pharmaceutical and natural products research and development. This free service provides target screening using a library of HPLC and SFC columns including the Phenomenex Lux polysaccharide-based offerings. After resolv ... more
Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions. These solutions help researchers in industrial, government and academic laboratories to solve their daily analytical challenges. Our solutions for Reversed Phase HPLC user include Kinetex® ... more
Founded in 1982, Phenomenex is dedicated to the development, manufacturing and supply of key products used in the analysis and purification of chemicals and biochemicals. more
Phenomenex, founded in 1982, is a global technology leader and innovator in the development of separation, purification and analytical chemistry solutions for life science, environmental, chemical manufacturing and related applications. Phenomenex products help customers streamline laborat ... more
Danaher To Acquire Pall Corporation
Danaher Corporation announced that it has entered into a definitive merger agreement with Pall Corporation pursuant to which Danaher will acquire all of the outstanding shares of Pall for $127.20 per share in cash, or a total enterprise value of approximately $13.8 billion, including assume ... more
Danaher to Acquire Beckman Coulter, Inc. for $6.8 Billion
Danaher Corporation announced that it has entered into a definitive merger agreement with Beckman Coulter, Inc. pursuant to which Danaher will acquire Beckman Coulter by making a cash tender offer to acquire all of the outstanding shares of common stock of Beckman Coulter at a purchase ... more
Life Technologies to Sell Mass Spectrometry Business to Danaher for $450 Million in Cash
Life Technologies Corporation announced it has signed a definitive agreement to sell its ownership stake in its mass spectrometry business, operated as a joint venture, to Danaher Corporation for $450 million in cash. Danaher has also signed an agreement to acquire Life Technologies’ joint ... more
